Axogen, Inc. (AXGN)

↓ Download CSV

CIK 0000805928 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated MN
  • Fiscal year ends Dec 31

In fiscal 2025, Axogen, Inc. reported revenue of $225.21M, up 20.2% from the prior year. The company ran a net loss, with a net margin of -7.0% and a gross margin of 74.3%. It held $221.69M in total assets against $92.84M in total liabilities.

Key ratios (FY2025)

74.3%
Gross margin
-3.5%
Operating margin
-7.0%
Net margin
-12.2%
Return on equity
+20.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$225.21M$187.34M$159.01M$138.58M$127.36M$112.30M$106.71M$83.94M$60.43M$41.11M
Cost of Revenue$57.85M$45.36M$37.14M$29.77M$22.93M$21.58M$17.35M$12.92M$9.31M$6.47M
Gross Profit$167.35M$141.98M$121.87M$108.81M$104.43M$90.72M$89.36M$71.01M$51.12M$34.64M
Operating Income-$7.85M-$3.29M-$21.46M-$29.71M-$25.42M-$23.18M-$31.41M-$20.50M-$7.95M-$8.13M
Net Income-$15.70M-$9.96M-$21.72M-$28.95M-$26.98M-$23.79M-$29.14M-$22.40M-$10.45M-$14.41M
EPS (Diluted)$-0.34$-0.23$-0.51$-0.69$-0.65$-0.60$-0.74
Total Assets$221.69M$203.73M$196.83M$195.39M$208.02M$201.38M$154.64M$160.17M$58.88M$46.36M
Total Liabilities$92.84M$99.82M$101.16M$94.39M$95.47M$78.23M$22.49M$13.19M$33.69M$31.44M
Shareholders' Equity$128.85M$103.91M$95.67M$101.00M$112.55M$123.15M$132.15M$146.98M$25.18M$14.92M
Cash & Equivalents$35.55M$27.55M$31.02M$15.28M$32.76M$48.77M$35.72M$24.29M$36.51M$30.01M
Operating Cash Flow$812.0K$4.54M-$5.72M-$16.07M-$13.40M-$9.63M-$19.87M-$17.86M-$9.24M-$11.24M
Capital Expenditures$3.75M$3.10M$13.87M$20.08M$27.81M$21.91M$4.66M$6.28M$1.10M$931.0K
Shares Outstanding47.20M44.15M43.12M42.45M41.74M40.62M39.59M38.90M34.35M33.01M